Are you struggling to understand the timing required to get a brand name approved? Or the considerations to take after a rejection, withdrawal or proposal of a new name? The answer to these questions and related questions is – PDUFA!
We recently read an article that stated “branding is something you do after someone has bought from you, rather than something you do to induce them to buy from you” – and we take issue with that statement.
In a world completely inundated with information, where voices struggle to be heard over one another, it has become increasingly common that we marginalize the perspectives that deserve to be the loudest ones heard.
When creating your positioning strategy, there are two main aspects to use as starting points – function or feeling. But which one’s right for your brand?
Too difficult. Unoriginal. Hard to remember. These are the words that no company wants to hear about their latest brand name. This is especially true in the pharmaceutical industry, where the name of a drug is crucial to its approval and success. How can a blank canvas naming strategy address these concerns?
As brands and logos have evolved over the last several years, it’s become evident that simplicity and minimalistic design are key directions for modern brand marketing.
Learn how the alignment of brand and business strategy can enliven internal teams, sharpen external communication and unleash market success.
How your brand presents itself through the transition could make a big impact on both customers and employees.
A brand is a vessel carrying values and beliefs that consumers associate with a product or service, but it doesn’t start out that way.
In June the EMA NRG held their annual meeting to discuss guidelines, best practices and trends for invented name submissions. Review our summary to stay up-to-date on the latest changes.
If AI is the wave of the future, we must keep in mind the shortcomings: right now smart computer systems only consider the tip of the iceberg when it comes to drug naming.
Biosimilars are one of the most exciting breakthroughs in the pharmaceutical space in years, providing an entirely new category of products to reach patients. But with this new innovation comes new branding challenges.
2017 was a busy year for regulatory updates. Download our webinar to learn more about the changes we saw within the FDA, EMA and Health Canada.
Mergers, acquisitions, restructurings – don’t let your brand suffer during times of change at the corporate level.
How to build a brand in a way that successfully communicates the previously unseen nature of innovation? The answer can be found in one word – differentiation.
Do you choose a name that is “safe” and has a good chance at regulatory approval, or to take the more “risky” route, with a name that might have a more difficult time getting approved but stands out?
Just like you wouldn't build a house without a blueprint created, you shouldn't build a brand without a brand architecture strategy in place. Find out why this strategic brand element can drive all of your brand development decisions.
Branding clinical trials helps you begin building equity in your clinical asset in its earliest phases of development. Find out how this benefits you, your patients and even investors.
Creating and growing any business is a process that can take large amounts of time and energy to achieve – that’s a given. It’s a question we hear all of the time – “why do I need to create a brand? Why branding?”
Creating a brand name with links back to the science of the product holds a number of benefits and advantages across your brand.
Is there something “off” with your brand, and you can’t figure out what it is? Chances are, your brand is in need of a refresh.
Is it possible to convey both competence and warmth in a logo? Unity and inclusion? Strength and kindness? The answer to all of the above is yes and no. It’s certainly possible for a logo to convey any or all of those things – just not on its own.
We’ve compiled answers for the 11 most frequently asked questions surrounding pharmaceutical branding we receive today to help you with your next project.
How often have you scanned the store shelves looking for a product, and a particular one caught your eye, making you stop, do a double-take or spend a few additional seconds focusing on that one product before moving on? Well, those few seconds and that additional look were not a coincidence.
Naming an OTC drug product is the rare instance in pharma naming when pre- and post-launch planning are so closely intertwined, which can pose some challenges. But it can also some uniquely interesting opportunities. What do you need to keep in mind when working on this type of product?
It has been said that you never get a second chance to make a first impression. For many new assets the clinical trial stage of development is that first impression, a chance to ensure that moving forward, their brand is set up for success.
How can your colors push your brand forward, and what do you need to keep in mind when making decisions about your color palette?
When creating a pharma brand name, the thin line must be walked between creating a name that will have both a strong opportunity for regulatory approval and the recipe for market success.
In the summer of 2015, Health Canada released an updated guidance for their name submission process. Almost two years later, found an impact that goes beyond the Canadian pharmaceutical market.